nodes	percent_of_prediction	percent_of_DWPC	metapath
Orciprenaline—ADRB2—Adrenoceptors—ADRB3—type 2 diabetes mellitus	0.00929	0.0983	CbGpPWpGaD
Orciprenaline—Isoprenaline—PIK3R1—type 2 diabetes mellitus	0.00915	0.329	CrCbGaD
Orciprenaline—Fenoterol—ADRB3—type 2 diabetes mellitus	0.00677	0.244	CrCbGaD
Orciprenaline—ADRB2—Adrenoceptors—ADRA2A—type 2 diabetes mellitus	0.00609	0.0644	CbGpPWpGaD
Orciprenaline—Isoprenaline—ADRB3—type 2 diabetes mellitus	0.00331	0.119	CrCbGaD
Orciprenaline—ADRB2—Monoamine GPCRs—ADRB3—type 2 diabetes mellitus	0.00329	0.0348	CbGpPWpGaD
Orciprenaline—Epinephrine—ADRB3—type 2 diabetes mellitus	0.00278	0.1	CrCbGaD
Orciprenaline—ADRB2—Amine ligand-binding receptors—ADRB3—type 2 diabetes mellitus	0.00276	0.0292	CbGpPWpGaD
Orciprenaline—ADRB2—Monoamine GPCRs—HTR2C—type 2 diabetes mellitus	0.00226	0.0239	CbGpPWpGaD
Orciprenaline—ADRB2—Monoamine GPCRs—ADRA2A—type 2 diabetes mellitus	0.00215	0.0228	CbGpPWpGaD
Orciprenaline—ADRB2—Amine ligand-binding receptors—HTR2C—type 2 diabetes mellitus	0.0019	0.0201	CbGpPWpGaD
Orciprenaline—Phenylephrine—CYP1A2—type 2 diabetes mellitus	0.00188	0.0677	CrCbGaD
Orciprenaline—ADRB2—Amine ligand-binding receptors—ADRA2A—type 2 diabetes mellitus	0.00181	0.0191	CbGpPWpGaD
Orciprenaline—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.00168	0.00191	CcSEcCtD
Orciprenaline—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.00168	0.00191	CcSEcCtD
Orciprenaline—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.00167	0.00191	CcSEcCtD
Orciprenaline—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00167	0.0019	CcSEcCtD
Orciprenaline—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.00167	0.0019	CcSEcCtD
Orciprenaline—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00167	0.0019	CcSEcCtD
Orciprenaline—Cough—Gliclazide—type 2 diabetes mellitus	0.00167	0.0019	CcSEcCtD
Orciprenaline—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00166	0.00189	CcSEcCtD
Orciprenaline—ADRB2—G alpha (s) signalling events—GCGR—type 2 diabetes mellitus	0.00165	0.0175	CbGpPWpGaD
Orciprenaline—Vision blurred—Valsartan—type 2 diabetes mellitus	0.00165	0.00188	CcSEcCtD
Orciprenaline—Hypertension—Gliclazide—type 2 diabetes mellitus	0.00165	0.00188	CcSEcCtD
Orciprenaline—Chills—Metformin—type 2 diabetes mellitus	0.00165	0.00188	CcSEcCtD
Orciprenaline—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00164	0.00187	CcSEcCtD
Orciprenaline—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00163	0.00186	CcSEcCtD
Orciprenaline—Myalgia—Gliclazide—type 2 diabetes mellitus	0.00163	0.00185	CcSEcCtD
Orciprenaline—Chest pain—Gliclazide—type 2 diabetes mellitus	0.00163	0.00185	CcSEcCtD
Orciprenaline—Nausea—Repaglinide—type 2 diabetes mellitus	0.00162	0.00184	CcSEcCtD
Orciprenaline—Asthenia—Glipizide—type 2 diabetes mellitus	0.00162	0.00184	CcSEcCtD
Orciprenaline—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00161	0.00184	CcSEcCtD
Orciprenaline—Pruritus—Glipizide—type 2 diabetes mellitus	0.0016	0.00182	CcSEcCtD
Orciprenaline—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00159	0.00181	CcSEcCtD
Orciprenaline—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.00159	0.00181	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.00158	0.0018	CcSEcCtD
Orciprenaline—Syncope—Valsartan—type 2 diabetes mellitus	0.00157	0.00179	CcSEcCtD
Orciprenaline—Dysgeusia—Metformin—type 2 diabetes mellitus	0.00156	0.00178	CcSEcCtD
Orciprenaline—Chills—Irbesartan—type 2 diabetes mellitus	0.00155	0.00177	CcSEcCtD
Orciprenaline—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00155	0.00177	CcSEcCtD
Orciprenaline—Palpitations—Valsartan—type 2 diabetes mellitus	0.00155	0.00177	CcSEcCtD
Orciprenaline—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00155	0.00177	CcSEcCtD
Orciprenaline—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.00155	0.00176	CcSEcCtD
Orciprenaline—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00155	0.00176	CcSEcCtD
Orciprenaline—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00154	0.00176	CcSEcCtD
Orciprenaline—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00154	0.00176	CcSEcCtD
Orciprenaline—Muscle spasms—Metformin—type 2 diabetes mellitus	0.00154	0.00175	CcSEcCtD
Orciprenaline—Palpitations—Orlistat—type 2 diabetes mellitus	0.00153	0.00175	CcSEcCtD
Orciprenaline—Cough—Valsartan—type 2 diabetes mellitus	0.00153	0.00174	CcSEcCtD
Orciprenaline—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00153	0.00174	CcSEcCtD
Orciprenaline—ADRB2—G alpha (s) signalling events—GIPR—type 2 diabetes mellitus	0.00152	0.0161	CbGpPWpGaD
Orciprenaline—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00152	0.00173	CcSEcCtD
Orciprenaline—Cough—Orlistat—type 2 diabetes mellitus	0.00151	0.00172	CcSEcCtD
Orciprenaline—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00151	0.00172	CcSEcCtD
Orciprenaline—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00151	0.00172	CcSEcCtD
Orciprenaline—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00151	0.00172	CcSEcCtD
Orciprenaline—Vision blurred—Metformin—type 2 diabetes mellitus	0.00151	0.00172	CcSEcCtD
Orciprenaline—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00151	0.00172	CcSEcCtD
Orciprenaline—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.0015	0.00171	CcSEcCtD
Orciprenaline—Tremor—Metformin—type 2 diabetes mellitus	0.0015	0.00171	CcSEcCtD
Orciprenaline—Chest pain—Valsartan—type 2 diabetes mellitus	0.00149	0.0017	CcSEcCtD
Orciprenaline—Myalgia—Valsartan—type 2 diabetes mellitus	0.00149	0.0017	CcSEcCtD
Orciprenaline—Sweating—Ramipril—type 2 diabetes mellitus	0.00149	0.0017	CcSEcCtD
Orciprenaline—Dizziness—Glipizide—type 2 diabetes mellitus	0.00149	0.0017	CcSEcCtD
Orciprenaline—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00149	0.0017	CcSEcCtD
Orciprenaline—Tension—Irbesartan—type 2 diabetes mellitus	0.00148	0.00169	CcSEcCtD
Orciprenaline—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00148	0.00168	CcSEcCtD
Orciprenaline—ADRB2—Arf6 trafficking events—SLC2A4—type 2 diabetes mellitus	0.00148	0.0156	CbGpPWpGaD
Orciprenaline—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.00148	0.00168	CcSEcCtD
Orciprenaline—Myalgia—Orlistat—type 2 diabetes mellitus	0.00148	0.00168	CcSEcCtD
Orciprenaline—Chest pain—Orlistat—type 2 diabetes mellitus	0.00148	0.00168	CcSEcCtD
Orciprenaline—Nervousness—Irbesartan—type 2 diabetes mellitus	0.00146	0.00167	CcSEcCtD
Orciprenaline—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00146	0.00166	CcSEcCtD
Orciprenaline—Arrhythmia—Losartan—type 2 diabetes mellitus	0.00146	0.00166	CcSEcCtD
Orciprenaline—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.00145	0.00165	CcSEcCtD
Orciprenaline—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00144	0.00164	CcSEcCtD
Orciprenaline—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00144	0.00164	CcSEcCtD
Orciprenaline—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00144	0.00164	CcSEcCtD
Orciprenaline—Vomiting—Glipizide—type 2 diabetes mellitus	0.00143	0.00163	CcSEcCtD
Orciprenaline—Syncope—Metformin—type 2 diabetes mellitus	0.00143	0.00163	CcSEcCtD
Orciprenaline—Oedema—Valsartan—type 2 diabetes mellitus	0.00143	0.00163	CcSEcCtD
Orciprenaline—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00143	0.00163	CcSEcCtD
Orciprenaline—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00143	0.00163	CcSEcCtD
Orciprenaline—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00142	0.00162	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00142	0.00162	CcSEcCtD
Orciprenaline—Oedema—Orlistat—type 2 diabetes mellitus	0.00141	0.00161	CcSEcCtD
Orciprenaline—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00141	0.00161	CcSEcCtD
Orciprenaline—Headache—Glipizide—type 2 diabetes mellitus	0.00141	0.00161	CcSEcCtD
Orciprenaline—Tremor—Irbesartan—type 2 diabetes mellitus	0.00141	0.00161	CcSEcCtD
Orciprenaline—Palpitations—Metformin—type 2 diabetes mellitus	0.00141	0.00161	CcSEcCtD
Orciprenaline—Insomnia—Gliclazide—type 2 diabetes mellitus	0.00141	0.00161	CcSEcCtD
Orciprenaline—Shock—Valsartan—type 2 diabetes mellitus	0.00141	0.00161	CcSEcCtD
Orciprenaline—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.0014	0.0016	CcSEcCtD
Orciprenaline—Tension—Losartan—type 2 diabetes mellitus	0.00139	0.00159	CcSEcCtD
Orciprenaline—ADRB2—G alpha (s) signalling events—MC4R—type 2 diabetes mellitus	0.00139	0.0147	CbGpPWpGaD
Orciprenaline—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00139	0.00159	CcSEcCtD
Orciprenaline—Dysgeusia—Losartan—type 2 diabetes mellitus	0.00139	0.00158	CcSEcCtD
Orciprenaline—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00139	0.00158	CcSEcCtD
Orciprenaline—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00139	0.00158	CcSEcCtD
Orciprenaline—Hypertension—Metformin—type 2 diabetes mellitus	0.00138	0.00157	CcSEcCtD
Orciprenaline—Urticaria—Glyburide—type 2 diabetes mellitus	0.00138	0.00157	CcSEcCtD
Orciprenaline—Nervousness—Losartan—type 2 diabetes mellitus	0.00138	0.00157	CcSEcCtD
Orciprenaline—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00137	0.00156	CcSEcCtD
Orciprenaline—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00136	0.00155	CcSEcCtD
Orciprenaline—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00136	0.00155	CcSEcCtD
Orciprenaline—Myalgia—Metformin—type 2 diabetes mellitus	0.00136	0.00155	CcSEcCtD
Orciprenaline—Chest pain—Metformin—type 2 diabetes mellitus	0.00136	0.00155	CcSEcCtD
Orciprenaline—Headache—Pioglitazone—type 2 diabetes mellitus	0.00135	0.00154	CcSEcCtD
Orciprenaline—Syncope—Irbesartan—type 2 diabetes mellitus	0.00135	0.00154	CcSEcCtD
Orciprenaline—ADRB2—Calcium Regulation in the Cardiac Cell—PLN—type 2 diabetes mellitus	0.00135	0.0143	CbGpPWpGaD
Orciprenaline—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00134	0.00153	CcSEcCtD
Orciprenaline—ADRB2—G alpha (s) signalling events—GIP—type 2 diabetes mellitus	0.00134	0.0142	CbGpPWpGaD
Orciprenaline—Nausea—Glipizide—type 2 diabetes mellitus	0.00134	0.00153	CcSEcCtD
Orciprenaline—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00134	0.00152	CcSEcCtD
Orciprenaline—Vision blurred—Losartan—type 2 diabetes mellitus	0.00134	0.00152	CcSEcCtD
Orciprenaline—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00133	0.00152	CcSEcCtD
Orciprenaline—Pain—Gliclazide—type 2 diabetes mellitus	0.00133	0.00152	CcSEcCtD
Orciprenaline—Tremor—Losartan—type 2 diabetes mellitus	0.00133	0.00151	CcSEcCtD
Orciprenaline—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.00133	0.00151	CcSEcCtD
Orciprenaline—Headache—Glimepiride—type 2 diabetes mellitus	0.00132	0.0015	CcSEcCtD
Orciprenaline—Cough—Irbesartan—type 2 diabetes mellitus	0.00132	0.0015	CcSEcCtD
Orciprenaline—ADRB2—Calcium Regulation in the Cardiac Cell—GRK5—type 2 diabetes mellitus	0.00131	0.0139	CbGpPWpGaD
Orciprenaline—Headache—Sitagliptin—type 2 diabetes mellitus	0.00131	0.0015	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.0013	0.00149	CcSEcCtD
Orciprenaline—Oedema—Metformin—type 2 diabetes mellitus	0.0013	0.00149	CcSEcCtD
Orciprenaline—Hypertension—Irbesartan—type 2 diabetes mellitus	0.0013	0.00148	CcSEcCtD
Orciprenaline—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.0013	0.00148	CcSEcCtD
Orciprenaline—Insomnia—Valsartan—type 2 diabetes mellitus	0.0013	0.00148	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00129	0.00147	CcSEcCtD
Orciprenaline—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00128	0.00146	CcSEcCtD
Orciprenaline—Chest pain—Irbesartan—type 2 diabetes mellitus	0.00128	0.00146	CcSEcCtD
Orciprenaline—Shock—Metformin—type 2 diabetes mellitus	0.00128	0.00146	CcSEcCtD
Orciprenaline—Insomnia—Orlistat—type 2 diabetes mellitus	0.00128	0.00146	CcSEcCtD
Orciprenaline—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00128	0.00146	CcSEcCtD
Orciprenaline—Somnolence—Valsartan—type 2 diabetes mellitus	0.00127	0.00145	CcSEcCtD
Orciprenaline—Syncope—Losartan—type 2 diabetes mellitus	0.00127	0.00145	CcSEcCtD
Orciprenaline—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00126	0.00144	CcSEcCtD
Orciprenaline—Epinephrine—ADRA2A—type 2 diabetes mellitus	0.00126	0.0453	CrCbGaD
Orciprenaline—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00126	0.00143	CcSEcCtD
Orciprenaline—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00126	0.00143	CcSEcCtD
Orciprenaline—Palpitations—Losartan—type 2 diabetes mellitus	0.00125	0.00143	CcSEcCtD
Orciprenaline—Nausea—Glimepiride—type 2 diabetes mellitus	0.00125	0.00142	CcSEcCtD
Orciprenaline—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.00125	0.00142	CcSEcCtD
Orciprenaline—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.00125	0.00142	CcSEcCtD
Orciprenaline—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00125	0.00142	CcSEcCtD
Orciprenaline—Asthenia—Glyburide—type 2 diabetes mellitus	0.00125	0.00142	CcSEcCtD
Orciprenaline—Cough—Losartan—type 2 diabetes mellitus	0.00124	0.00141	CcSEcCtD
Orciprenaline—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00124	0.00141	CcSEcCtD
Orciprenaline—Fatigue—Valsartan—type 2 diabetes mellitus	0.00123	0.00141	CcSEcCtD
Orciprenaline—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00123	0.0014	CcSEcCtD
Orciprenaline—Oedema—Irbesartan—type 2 diabetes mellitus	0.00123	0.0014	CcSEcCtD
Orciprenaline—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00123	0.0014	CcSEcCtD
Orciprenaline—Pruritus—Glyburide—type 2 diabetes mellitus	0.00123	0.0014	CcSEcCtD
Orciprenaline—Fatigue—Orlistat—type 2 diabetes mellitus	0.00122	0.00139	CcSEcCtD
Orciprenaline—Shock—Irbesartan—type 2 diabetes mellitus	0.00121	0.00138	CcSEcCtD
Orciprenaline—Pain—Orlistat—type 2 diabetes mellitus	0.00121	0.00138	CcSEcCtD
Orciprenaline—Myalgia—Losartan—type 2 diabetes mellitus	0.00121	0.00138	CcSEcCtD
Orciprenaline—Chest pain—Losartan—type 2 diabetes mellitus	0.00121	0.00138	CcSEcCtD
Orciprenaline—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00121	0.00138	CcSEcCtD
Orciprenaline—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.0012	0.00137	CcSEcCtD
Orciprenaline—Tension—Ramipril—type 2 diabetes mellitus	0.00119	0.00136	CcSEcCtD
Orciprenaline—Epinephrine—TNF—type 2 diabetes mellitus	0.00119	0.0429	CrCbGaD
Orciprenaline—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.00119	0.00136	CcSEcCtD
Orciprenaline—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00119	0.00136	CcSEcCtD
Orciprenaline—Headache—Bromocriptine—type 2 diabetes mellitus	0.00119	0.00136	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00119	0.00135	CcSEcCtD
Orciprenaline—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00119	0.00135	CcSEcCtD
Orciprenaline—Nervousness—Ramipril—type 2 diabetes mellitus	0.00118	0.00135	CcSEcCtD
Orciprenaline—Dry mouth—Losartan—type 2 diabetes mellitus	0.00118	0.00135	CcSEcCtD
Orciprenaline—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.00117	0.00133	CcSEcCtD
Orciprenaline—Somnolence—Metformin—type 2 diabetes mellitus	0.00116	0.00132	CcSEcCtD
Orciprenaline—Oedema—Losartan—type 2 diabetes mellitus	0.00116	0.00132	CcSEcCtD
Orciprenaline—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00116	0.00132	CcSEcCtD
Orciprenaline—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00115	0.00131	CcSEcCtD
Orciprenaline—Tremor—Ramipril—type 2 diabetes mellitus	0.00114	0.0013	CcSEcCtD
Orciprenaline—ADRB2—G alpha (s) signalling events—ADRB3—type 2 diabetes mellitus	0.00114	0.0121	CbGpPWpGaD
Orciprenaline—Shock—Losartan—type 2 diabetes mellitus	0.00114	0.0013	CcSEcCtD
Orciprenaline—Urticaria—Valsartan—type 2 diabetes mellitus	0.00114	0.0013	CcSEcCtD
Orciprenaline—Tachycardia—Losartan—type 2 diabetes mellitus	0.00113	0.00129	CcSEcCtD
Orciprenaline—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00113	0.00128	CcSEcCtD
Orciprenaline—Fatigue—Metformin—type 2 diabetes mellitus	0.00112	0.00128	CcSEcCtD
Orciprenaline—Urticaria—Orlistat—type 2 diabetes mellitus	0.00112	0.00128	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00112	0.00128	CcSEcCtD
Orciprenaline—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00112	0.00128	CcSEcCtD
Orciprenaline—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00112	0.00127	CcSEcCtD
Orciprenaline—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00112	0.00127	CcSEcCtD
Orciprenaline—Vomiting—Glyburide—type 2 diabetes mellitus	0.0011	0.00126	CcSEcCtD
Orciprenaline—Pruritus—Gliclazide—type 2 diabetes mellitus	0.0011	0.00126	CcSEcCtD
Orciprenaline—ADRB2—G alpha (s) signalling events—CRHR1—type 2 diabetes mellitus	0.0011	0.0116	CbGpPWpGaD
Orciprenaline—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00109	0.00125	CcSEcCtD
Orciprenaline—Syncope—Ramipril—type 2 diabetes mellitus	0.00109	0.00124	CcSEcCtD
Orciprenaline—Headache—Glyburide—type 2 diabetes mellitus	0.00109	0.00124	CcSEcCtD
Orciprenaline—Palpitations—Ramipril—type 2 diabetes mellitus	0.00108	0.00123	CcSEcCtD
Orciprenaline—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.00107	0.00122	CcSEcCtD
Orciprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1A—type 2 diabetes mellitus	0.00107	0.0113	CbGpPWpGaD
Orciprenaline—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00107	0.00121	CcSEcCtD
Orciprenaline—Cough—Ramipril—type 2 diabetes mellitus	0.00106	0.00121	CcSEcCtD
Orciprenaline—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00106	0.00121	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00106	0.0012	CcSEcCtD
Orciprenaline—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00105	0.0012	CcSEcCtD
Orciprenaline—Pain—Irbesartan—type 2 diabetes mellitus	0.00105	0.0012	CcSEcCtD
Orciprenaline—ADRB2—Calcium Regulation in the Cardiac Cell—ATP2A3—type 2 diabetes mellitus	0.00105	0.0111	CbGpPWpGaD
Orciprenaline—Insomnia—Losartan—type 2 diabetes mellitus	0.00105	0.00119	CcSEcCtD
Orciprenaline—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00104	0.00119	CcSEcCtD
Orciprenaline—Urticaria—Metformin—type 2 diabetes mellitus	0.00104	0.00118	CcSEcCtD
Orciprenaline—Chest pain—Ramipril—type 2 diabetes mellitus	0.00104	0.00118	CcSEcCtD
Orciprenaline—Myalgia—Ramipril—type 2 diabetes mellitus	0.00104	0.00118	CcSEcCtD
Orciprenaline—Nausea—Glyburide—type 2 diabetes mellitus	0.00103	0.00117	CcSEcCtD
Orciprenaline—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00103	0.00117	CcSEcCtD
Orciprenaline—Somnolence—Losartan—type 2 diabetes mellitus	0.00103	0.00117	CcSEcCtD
Orciprenaline—Asthenia—Valsartan—type 2 diabetes mellitus	0.00103	0.00117	CcSEcCtD
Orciprenaline—Asthenia—Orlistat—type 2 diabetes mellitus	0.00102	0.00116	CcSEcCtD
Orciprenaline—Pruritus—Valsartan—type 2 diabetes mellitus	0.00101	0.00115	CcSEcCtD
Orciprenaline—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00101	0.00115	CcSEcCtD
Orciprenaline—Pruritus—Orlistat—type 2 diabetes mellitus	0.001	0.00114	CcSEcCtD
Orciprenaline—Fatigue—Losartan—type 2 diabetes mellitus	0.000998	0.00114	CcSEcCtD
Orciprenaline—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000993	0.00113	CcSEcCtD
Orciprenaline—Oedema—Ramipril—type 2 diabetes mellitus	0.000993	0.00113	CcSEcCtD
Orciprenaline—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000991	0.00113	CcSEcCtD
Orciprenaline—Pain—Losartan—type 2 diabetes mellitus	0.00099	0.00113	CcSEcCtD
Orciprenaline—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB3—type 2 diabetes mellitus	0.000984	0.0104	CbGpPWpGaD
Orciprenaline—ADRB2—G alpha (s) signalling events—GLP1R—type 2 diabetes mellitus	0.000981	0.0104	CbGpPWpGaD
Orciprenaline—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00098	0.00112	CcSEcCtD
Orciprenaline—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000978	0.00111	CcSEcCtD
Orciprenaline—ADRB2—GPCRs, Other—EDNRA—type 2 diabetes mellitus	0.000977	0.0103	CbGpPWpGaD
Orciprenaline—Shock—Ramipril—type 2 diabetes mellitus	0.000977	0.00111	CcSEcCtD
Orciprenaline—Headache—Gliclazide—type 2 diabetes mellitus	0.000976	0.00111	CcSEcCtD
Orciprenaline—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000973	0.00111	CcSEcCtD
Orciprenaline—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000969	0.0011	CcSEcCtD
Orciprenaline—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000968	0.0011	CcSEcCtD
Orciprenaline—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.00096	0.00109	CcSEcCtD
Orciprenaline—Dizziness—Valsartan—type 2 diabetes mellitus	0.000947	0.00108	CcSEcCtD
Orciprenaline—Dizziness—Orlistat—type 2 diabetes mellitus	0.000936	0.00107	CcSEcCtD
Orciprenaline—Asthenia—Metformin—type 2 diabetes mellitus	0.000936	0.00107	CcSEcCtD
Orciprenaline—Nausea—Gliclazide—type 2 diabetes mellitus	0.000926	0.00105	CcSEcCtD
Orciprenaline—Pruritus—Metformin—type 2 diabetes mellitus	0.000923	0.00105	CcSEcCtD
Orciprenaline—Urticaria—Losartan—type 2 diabetes mellitus	0.00092	0.00105	CcSEcCtD
Orciprenaline—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000915	0.00104	CcSEcCtD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1A—type 2 diabetes mellitus	0.000914	0.00967	CbGpPWpGaD
Orciprenaline—Vomiting—Valsartan—type 2 diabetes mellitus	0.00091	0.00104	CcSEcCtD
Orciprenaline—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000907	0.00103	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000905	0.00103	CcSEcCtD
Orciprenaline—Vomiting—Orlistat—type 2 diabetes mellitus	0.0009	0.00102	CcSEcCtD
Orciprenaline—Insomnia—Ramipril—type 2 diabetes mellitus	0.000898	0.00102	CcSEcCtD
Orciprenaline—Headache—Valsartan—type 2 diabetes mellitus	0.000897	0.00102	CcSEcCtD
Orciprenaline—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000892	0.00102	CcSEcCtD
Orciprenaline—Headache—Orlistat—type 2 diabetes mellitus	0.000886	0.00101	CcSEcCtD
Orciprenaline—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000883	0.00101	CcSEcCtD
Orciprenaline—Somnolence—Ramipril—type 2 diabetes mellitus	0.000883	0.00101	CcSEcCtD
Orciprenaline—Epinephrine—CYP1A2—type 2 diabetes mellitus	0.000873	0.0314	CrCbGaD
Orciprenaline—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000871	0.000992	CcSEcCtD
Orciprenaline—ADRB2—G alpha (s) signalling events—IAPP—type 2 diabetes mellitus	0.000869	0.00919	CbGpPWpGaD
Orciprenaline—Dizziness—Metformin—type 2 diabetes mellitus	0.000862	0.000982	CcSEcCtD
Orciprenaline—Fatigue—Ramipril—type 2 diabetes mellitus	0.000856	0.000975	CcSEcCtD
Orciprenaline—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000853	0.000972	CcSEcCtD
Orciprenaline—Nausea—Valsartan—type 2 diabetes mellitus	0.000851	0.000969	CcSEcCtD
Orciprenaline—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000842	0.000959	CcSEcCtD
Orciprenaline—Nausea—Orlistat—type 2 diabetes mellitus	0.00084	0.000958	CcSEcCtD
Orciprenaline—Asthenia—Losartan—type 2 diabetes mellitus	0.000831	0.000947	CcSEcCtD
Orciprenaline—ADRB2—Arf6 trafficking events—INS—type 2 diabetes mellitus	0.00083	0.00878	CbGpPWpGaD
Orciprenaline—Vomiting—Metformin—type 2 diabetes mellitus	0.000829	0.000945	CcSEcCtD
Orciprenaline—Pruritus—Losartan—type 2 diabetes mellitus	0.000819	0.000934	CcSEcCtD
Orciprenaline—Headache—Metformin—type 2 diabetes mellitus	0.000817	0.000931	CcSEcCtD
Orciprenaline—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000814	0.000927	CcSEcCtD
Orciprenaline—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000792	0.000903	CcSEcCtD
Orciprenaline—Urticaria—Ramipril—type 2 diabetes mellitus	0.000789	0.000899	CcSEcCtD
Orciprenaline—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000785	0.000894	CcSEcCtD
Orciprenaline—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000782	0.000891	CcSEcCtD
Orciprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—MC4R—type 2 diabetes mellitus	0.000775	0.0082	CbGpPWpGaD
Orciprenaline—Nausea—Metformin—type 2 diabetes mellitus	0.000775	0.000882	CcSEcCtD
Orciprenaline—Headache—Irbesartan—type 2 diabetes mellitus	0.000771	0.000878	CcSEcCtD
Orciprenaline—Dizziness—Losartan—type 2 diabetes mellitus	0.000766	0.000873	CcSEcCtD
Orciprenaline—ADRB2—Calcium Regulation in the Cardiac Cell—ATP2A2—type 2 diabetes mellitus	0.000755	0.00799	CbGpPWpGaD
Orciprenaline—Vomiting—Losartan—type 2 diabetes mellitus	0.000736	0.000839	CcSEcCtD
Orciprenaline—ADRB2—G alpha (s) signalling events—CALCA—type 2 diabetes mellitus	0.000734	0.00777	CbGpPWpGaD
Orciprenaline—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000732	0.000834	CcSEcCtD
Orciprenaline—Nausea—Irbesartan—type 2 diabetes mellitus	0.000731	0.000833	CcSEcCtD
Orciprenaline—Headache—Losartan—type 2 diabetes mellitus	0.000726	0.000827	CcSEcCtD
Orciprenaline—Asthenia—Ramipril—type 2 diabetes mellitus	0.000712	0.000812	CcSEcCtD
Orciprenaline—Pruritus—Ramipril—type 2 diabetes mellitus	0.000703	0.0008	CcSEcCtD
Orciprenaline—ADRB2—GPCR ligand binding—MTNR1A—type 2 diabetes mellitus	0.000696	0.00736	CbGpPWpGaD
Orciprenaline—Nausea—Losartan—type 2 diabetes mellitus	0.000688	0.000784	CcSEcCtD
Orciprenaline—ADRB2—Arf6 signaling events—SRC—type 2 diabetes mellitus	0.000682	0.00721	CbGpPWpGaD
Orciprenaline—ADRB2—G alpha (s) signalling events—GCG—type 2 diabetes mellitus	0.00068	0.00719	CbGpPWpGaD
Orciprenaline—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000679	0.000774	CcSEcCtD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—MC4R—type 2 diabetes mellitus	0.000664	0.00702	CbGpPWpGaD
Orciprenaline—Dizziness—Ramipril—type 2 diabetes mellitus	0.000657	0.000748	CcSEcCtD
Orciprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB3—type 2 diabetes mellitus	0.000634	0.00671	CbGpPWpGaD
Orciprenaline—Vomiting—Ramipril—type 2 diabetes mellitus	0.000631	0.000719	CcSEcCtD
Orciprenaline—ADRB2—GPCRs, Other—CCR5—type 2 diabetes mellitus	0.00063	0.00666	CbGpPWpGaD
Orciprenaline—Headache—Ramipril—type 2 diabetes mellitus	0.000622	0.000709	CcSEcCtD
Orciprenaline—ADRB2—GPCR ligand binding—GCGR—type 2 diabetes mellitus	0.000601	0.00635	CbGpPWpGaD
Orciprenaline—ADRB2—Arf6 signaling events—EGFR—type 2 diabetes mellitus	0.000598	0.00632	CbGpPWpGaD
Orciprenaline—Nausea—Ramipril—type 2 diabetes mellitus	0.00059	0.000672	CcSEcCtD
Orciprenaline—ADRB2—G alpha (s) signalling events—GNB3—type 2 diabetes mellitus	0.000586	0.0062	CbGpPWpGaD
Orciprenaline—Epinephrine—CYP3A4—type 2 diabetes mellitus	0.000578	0.0208	CrCbGaD
Orciprenaline—ADRB2—G alpha (s) signalling events—AVP—type 2 diabetes mellitus	0.000578	0.00612	CbGpPWpGaD
Orciprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—type 2 diabetes mellitus	0.00056	0.00593	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—GIPR—type 2 diabetes mellitus	0.000553	0.00585	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB3—type 2 diabetes mellitus	0.000543	0.00575	CbGpPWpGaD
Orciprenaline—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—type 2 diabetes mellitus	0.000541	0.00573	CbGpPWpGaD
Orciprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—CCKAR—type 2 diabetes mellitus	0.000537	0.00568	CbGpPWpGaD
Orciprenaline—ADRB2—G alpha (s) signalling events—ADCY5—type 2 diabetes mellitus	0.000522	0.00553	CbGpPWpGaD
Orciprenaline—ADRB2—Calcium Regulation in the Cardiac Cell—GNB3—type 2 diabetes mellitus	0.000506	0.00535	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—MC4R—type 2 diabetes mellitus	0.000506	0.00535	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—GIP—type 2 diabetes mellitus	0.000487	0.00515	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—type 2 diabetes mellitus	0.00048	0.00508	CbGpPWpGaD
Orciprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—type 2 diabetes mellitus	0.000469	0.00497	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCKAR—type 2 diabetes mellitus	0.00046	0.00487	CbGpPWpGaD
Orciprenaline—ADRB2—Calcium Regulation in the Cardiac Cell—ADCY5—type 2 diabetes mellitus	0.000451	0.00477	CbGpPWpGaD
Orciprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRB—type 2 diabetes mellitus	0.00045	0.00476	CbGpPWpGaD
Orciprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—type 2 diabetes mellitus	0.000436	0.00462	CbGpPWpGaD
Orciprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—type 2 diabetes mellitus	0.000425	0.00449	CbGpPWpGaD
Orciprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—type 2 diabetes mellitus	0.000415	0.0044	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—ADRB3—type 2 diabetes mellitus	0.000414	0.00438	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—type 2 diabetes mellitus	0.000402	0.00426	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—CRHR1—type 2 diabetes mellitus	0.0004	0.00423	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—MTNR1A—type 2 diabetes mellitus	0.000393	0.00416	CbGpPWpGaD
Orciprenaline—ADRB2—Calcium Regulation in the Cardiac Cell—CALM1—type 2 diabetes mellitus	0.000388	0.0041	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRB—type 2 diabetes mellitus	0.000385	0.00408	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—type 2 diabetes mellitus	0.000374	0.00396	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—MTNR1B—type 2 diabetes mellitus	0.000365	0.00387	CbGpPWpGaD
Orciprenaline—ADRB2—Calcium Regulation in the Cardiac Cell—PRKCB—type 2 diabetes mellitus	0.000364	0.00385	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—type 2 diabetes mellitus	0.000364	0.00385	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—MTNR1A—type 2 diabetes mellitus	0.000357	0.00378	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—GLP1R—type 2 diabetes mellitus	0.000356	0.00377	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—type 2 diabetes mellitus	0.000356	0.00377	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—type 2 diabetes mellitus	0.000354	0.00375	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—CCKAR—type 2 diabetes mellitus	0.00035	0.00371	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—GCGR—type 2 diabetes mellitus	0.000339	0.00359	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—IAPP—type 2 diabetes mellitus	0.000315	0.00334	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—GIPR—type 2 diabetes mellitus	0.000312	0.0033	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—GRK5—type 2 diabetes mellitus	0.000312	0.0033	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—GCGR—type 2 diabetes mellitus	0.000308	0.00326	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	0.000306	0.00324	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	0.000293	0.0031	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—ARAP1—type 2 diabetes mellitus	0.000292	0.00309	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	0.000286	0.00302	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	0.000285	0.00301	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—GIPR—type 2 diabetes mellitus	0.000284	0.003	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—GRK5—type 2 diabetes mellitus	0.000284	0.003	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	0.000277	0.00293	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	0.000276	0.00292	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—GIP—type 2 diabetes mellitus	0.000275	0.00291	CbGpPWpGaD
Orciprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	0.000274	0.00289	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	0.000271	0.00287	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—GHRL—type 2 diabetes mellitus	0.00027	0.00286	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.000267	0.00282	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—CALCA—type 2 diabetes mellitus	0.000267	0.00282	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	0.000262	0.00277	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—MC4R—type 2 diabetes mellitus	0.000259	0.00274	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—GIP—type 2 diabetes mellitus	0.00025	0.00264	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—GCG—type 2 diabetes mellitus	0.000247	0.00261	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	0.000234	0.00248	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	0.000234	0.00247	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	0.000229	0.00242	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	0.000226	0.00239	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	0.000218	0.0023	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.000213	0.00225	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.000212	0.00225	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000211	0.00223	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.00021	0.00222	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.000207	0.00219	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.000205	0.00217	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.000201	0.00213	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.0002	0.00211	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.000198	0.0021	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000188	0.00198	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000183	0.00193	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000182	0.00193	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.00018	0.0019	CbGpPWpGaD
Orciprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.000179	0.0019	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000178	0.00189	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.000178	0.00189	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000174	0.00185	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000174	0.00184	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000173	0.00183	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000168	0.00177	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000168	0.00177	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000166	0.00175	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000166	0.00175	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000162	0.00171	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000161	0.0017	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000158	0.00167	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000157	0.00166	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000157	0.00166	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000153	0.00162	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000153	0.00162	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000153	0.00161	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000151	0.00159	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000151	0.00159	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000148	0.00156	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000146	0.00155	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000142	0.0015	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.00014	0.00148	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.00014	0.00148	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000139	0.00147	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000139	0.00147	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000137	0.00145	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000137	0.00145	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000136	0.00144	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000134	0.00142	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.00013	0.00138	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000127	0.00134	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000125	0.00133	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000125	0.00132	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000121	0.00128	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.00012	0.00127	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000119	0.00126	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000113	0.00119	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000112	0.00118	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000111	0.00117	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000111	0.00117	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000109	0.00116	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000108	0.00114	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000108	0.00114	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000108	0.00114	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000108	0.00114	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000107	0.00113	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000106	0.00112	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000102	0.00108	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000101	0.00107	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—C3—type 2 diabetes mellitus	9.86e-05	0.00104	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	9.73e-05	0.00103	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	9.62e-05	0.00102	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—IAPP—type 2 diabetes mellitus	9.56e-05	0.00101	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—INSR—type 2 diabetes mellitus	9.51e-05	0.00101	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	9.37e-05	0.000991	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	9.34e-05	0.000988	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	9.33e-05	0.000987	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	9.28e-05	0.000982	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	9.16e-05	0.000969	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	8.95e-05	0.000947	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	8.89e-05	0.000941	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	8.65e-05	0.000916	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	8.63e-05	0.000913	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	8.63e-05	0.000913	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	8.5e-05	0.0009	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	8.4e-05	0.000888	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	8.36e-05	0.000885	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	8.36e-05	0.000884	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	8.22e-05	0.000869	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.18e-05	0.000866	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.18e-05	0.000866	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.08e-05	0.000855	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	7.86e-05	0.000831	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.61e-05	0.000805	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	7.58e-05	0.000802	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.48e-05	0.000792	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	7.48e-05	0.000792	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.36e-05	0.000779	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.34e-05	0.000777	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7e-05	0.000741	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.88e-05	0.000728	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.87e-05	0.000727	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.51e-05	0.000689	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.45e-05	0.000682	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	6.36e-05	0.000673	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.36e-05	0.000673	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.34e-05	0.00067	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.31e-05	0.000667	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.24e-05	0.000661	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	6.15e-05	0.000651	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.13e-05	0.000648	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.05e-05	0.00064	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	5.87e-05	0.000621	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.75e-05	0.000608	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.51e-05	0.000583	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.41e-05	0.000572	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	5.29e-05	0.000559	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.04e-05	0.000534	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.03e-05	0.000532	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	5.02e-05	0.000532	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.94e-05	0.000523	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	4.92e-05	0.000521	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	4.92e-05	0.000521	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.87e-05	0.000515	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.64e-05	0.000491	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.39e-05	0.000465	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	4.21e-05	0.000445	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.14e-05	0.000438	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.07e-05	0.00043	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.06e-05	0.00043	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.05e-05	0.000428	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.86e-05	0.000409	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.69e-05	0.00039	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.69e-05	0.00039	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.47e-05	0.000367	CbGpPWpGaD
Orciprenaline—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.16e-05	0.000334	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.13e-05	0.000331	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.11e-05	0.000329	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.96e-05	0.000313	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.93e-05	0.00031	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.87e-05	0.000304	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.73e-05	0.000289	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.66e-05	0.000281	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.44e-05	0.000258	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.39e-05	0.000253	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.84e-05	0.000194	CbGpPWpGaD
Orciprenaline—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.7e-05	0.000179	CbGpPWpGaD
